LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Gas Critical Care Analyzer Features Broad Test Menu

By LabMedica International staff writers
Posted on 27 Sep 2011
A new blood gas critical care analyzer with a broad test menu is ideal for multiple testing locations including the Lab, operating room (OR), intensive care unit (ICU) and emergency department (ED).

The pHOx Ultra chemistry analyzers are used in critical care, point-of-care, and stat testing. pHOx Ultra analyzers measure up to 20 tests including blood gases, electrolytes, hemoglobin (Hb), hematocrit (Hct), glucose, lactate, creatinine, blood urea nitrogen (BUN), total bilirubin (tBil), and CO-oximetry. They feature auto-calibration, automated quality control, and automated maintenance.

The analyzer has a high resolution and large color touch screen that offers fast and easy operation. Bright color and graphic highlighting make it simple to read. Onboard, automated True quality control (QC) saves time and labor versus manual QC, and assures optimum analyzer performance.

The pHOx Ultra analyzer was developed and manufactured by Nova Biomedical (Waltham, MA, USA). Its complete onboard data manager can consolidate multiple, networked pHOx Ultras into a comprehensive database for capture, archiving, and extensive data reporting. It also provides a single hospital information system/laboratory information system (HIS/LIS) interface for multiple pHOx Ultras throughout a network, saving thousands of dollars in separate interface costs. Remote review and remote control of multiple, network connected analyzers can also be performed from the onboard Data Manager.

Related Links:
Nova Biomedical





Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
High Performance Centrifuge
CO336/336R

Latest Hematology News

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

WBC Count Could Predict Severity of COVID-19 Symptoms



Sekisui Diagnostics UK Ltd.